About Us

NephRx is a biotechnology company dedicated to the discovery and development of therapeutic products for the treatment of acute kidney failure/disease, and diseases of the gastrointestinal tract, including mucositis, Crohn’s Disease and ulcerative colitis.

Our portfolio of kidney and gastric growth factors is well covered by patents and patent disclosures in the USA and key countries throughout the world. The University of Chicago owns these patents and NephRx has negotiated an exclusive license agreement with the University for rights to these factors.

Partnership and Licensing Opportunities

NephRx is in preclinical development with both of its lead peptides, the kidney growth factor and the gastric growth factor. The company will consider development partnerships for one or both peptides. For more information, please contact:

James Koziarz, Ph.D President & CEO NephRx Corporation jkoziarz@nephrx.com

Proudly Located in Kalamazoo's